BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2867569)

  • 1. [Cobalt-activated acylase activity in patients treated with neuroleptics].
    Ketner M; Kramer M; Rosnowska M
    Psychiatr Pol; 1985; 19(1):30-5. PubMed ID: 2867569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the acylase test during neuroleptic therapy].
    Olajossy M; Modrzewska R
    Psychiatr Pol; 1980; 14(5):471-4. PubMed ID: 6110214
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cobalt-activated acylase activity as a new enzymatic test in viral hepatitis.
    Szewczuk A; Szczeklik A; Gladysz A
    Pol Med J; 1972; 11(6):1351-7. PubMed ID: 4659060
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic value of cobalt-activated acylase in viral hepatitis and its complications].
    Golus B; Kiczka W; Kryska A; Juszczyk J
    Pol Tyg Lek; 1978 Jan; 33(5):177-8. PubMed ID: 652639
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic value of determination of cobalt-activated acylase in acute and chronic hepatitis].
    Szczeklik A; Sowa J; Pawlikowski T
    Pol Arch Med Wewn; 1973; 50(10):1073-7. PubMed ID: 4757608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cobalt-activated acylase activity in the serum of patients with tuberculosis treated with antitubercular agents].
    Rzeszowska G; Radomińska I; Przemyska B; Modrzewska R; Szarewicz-Adamczyk W
    Wiad Lek; 1986 Apr; 39(7):444-8. PubMed ID: 3751033
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cobalt activated acylase in serum of patients poisoned with mushrooms].
    Szczeklik A; Wiernikowski A; Musial J; Woźny E
    Pol Tyg Lek; 1976 May; 31(20):849-51. PubMed ID: 951239
    [No Abstract]   [Full Text] [Related]  

  • 8. The behaviour of glycylaminopeptidase activity in the blood serum of patients with viral hepatitis and the comparison with cobalt-activated acylase activity.
    Szewczuk A; Barczyk-Luczykowa K; Przygodzka D
    Mater Med Pol; 1978; 10(1):9-13. PubMed ID: 642597
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of enzyme tests in the diagnosis of toxic hepatocellular damage].
    Chrostowski K; Milewski B
    Pol Tyg Lek; 1974 Oct; 29(41):1737-40. PubMed ID: 4154060
    [No Abstract]   [Full Text] [Related]  

  • 10. [Difficulties of the early diagnosis of the toxic liver damage (author's transl)].
    Habior A; Milewski B
    Przegl Lek; 1978; 35(2):297-300. PubMed ID: 652996
    [No Abstract]   [Full Text] [Related]  

  • 11. [Review of tests for the detection of liver damage due to drugs in man].
    Gielen J; Plomteux G
    Ann Biol Clin (Paris); 1968; 26(5):741-57. PubMed ID: 4878749
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatotoxicity associated with phenothiazines.
    Jones JK; Van de Carr SW; Zimmerman H; Leroy A
    Psychopharmacol Bull; 1983; 19(1):24-7. PubMed ID: 6131467
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum activity of cobalt-activated acylase in infectious mononucleosis].
    Modrzewska R; Rzeszowska G; Radomińska I; Patorska-Mach E
    Pol Tyg Lek; 1980 Dec; 35(51):2005-7. PubMed ID: 7243658
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of gamma-glutamyl transpeptidase as a screen test for liver tumour.
    Aronsen KF; Nosslin B; Pihl B
    Acta Chir Scand; 1970; 136(1):17-22. PubMed ID: 5518661
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients.
    Ishak KG; Irey NS
    Arch Pathol; 1972 Apr; 93(4):283-304. PubMed ID: 5017281
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver disease and phenothiazines. Involuntary movements.
    Ettinger M; Curran J
    Minn Med; 1970 Jul; 53(7):731-6. PubMed ID: 5427683
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of drug-induced hepatitis].
    Polunina TE
    Ter Arkh; 1988; 60(2):119-21. PubMed ID: 3368853
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities of assessment of preclinical forms of toxic hepatitis by evaluating oxidase activity of mixed liver function].
    Popov TA; Kaskevich LM
    Vrach Delo; 1977 Mar; (3):126-30. PubMed ID: 855275
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of serum glycylproline dipeptidyl aminopeptidase activity in the diagnosis of primary liver cancer].
    Ye SL
    Zhonghua Yi Xue Za Zhi; 1987 Mar; 67(3):134-6, 184. PubMed ID: 3111657
    [No Abstract]   [Full Text] [Related]  

  • 20. [Laboratory diagnosis of subclinical forms of chemically-induced liver damage].
    Lutz W; Kralkowska E
    Wiad Lek; 1986 Mar; 39(5):323-9. PubMed ID: 2873689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.